Angewandte Chemie International Edition · 2018 · 26 citations · 21 references
PharmacyMedicinal ChemistryMolecular BiologyDrug DesignDrug DiscoveryEpigeneticsLigand BindingProtein DesignProtein Interaction DomainsProtein TargetingProtein-ligand BindingTargeting LigandsBromodomain InhibitionBromodomain Protein TargetingBromodomain ProteinsEpigenetic Probe DesignLysine-targeted InhibitorsProbe Targeting LigandsSmall-molecule Epigenetic Modulators
Bromodomain-containing proteins are epigenetic modulators involved in a wide range of cellular processes, from recruitment of transcription factors to pathological disruption of gene regulation and cancer development. Since the druggability of these acetyl-lysine reader domains was established, efforts were made to develop potent and selective inhibitors across the entire family. Here we report the development of a small molecule-based approach to covalently modify recombinant and endogenous bromodomain-containing proteins by targeting a conserved lysine and a tyrosine residue in the variable ZA or BC loops. Moreover, the addition of a reporter tag allowed in-gel visualization and pull-down of the desired bromodomains.
21
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text